血清胆红素与心绞痛患者冠状动脉病变程度和预后的关系
作者:
作者单位:

(唐山工人医院心内二科,河北省唐山市 063000)

作者简介:

耿学斌,硕士,主任医师,研究方向为冠心病治疗,E-mail为xuebingeng@126.com。


Relationship between serum bilirubin and the severity of coronary artery lesion and prognosis in patients with angina
Author:
Affiliation:

Department of Cardiology, Tangshan Worker's Hospital, Tangshan, Hebei 063000, China)

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • | |
    摘要:

    目的 探讨血清胆红素与心绞痛患者冠状动脉病变程度和预后的关系。方法 以2013年1月1日至2015年12月31日期间在唐山工人医院诊治并符合条件的连续的486例冠心病患者为研究对象,男性292例,女性194例,平均年龄(61.4±13.2)岁。在出院前一天抽空腹静脉血检测总胆红素。回顾冠状动脉造影,采用SYNTAX评分系统对冠状动脉病变进行评分。本研究进行前瞻性随访,起点事件为经皮冠状动脉介入(PCI),终点事件为主要不良心血管事件(MACE),随访截止日期为2017年12月31日。应用多因素Logistic回归分析血清胆红素与SYNTAX评分之间的关系。生存率估算应用Kaplan-Meier法,两条生存曲线之间的比较采用log-rank检验,应用多变量Cox比例风险回归分析血清总胆红素与MACE之间的关系。结果 多因素Logistic回归分析表明,男性、年龄、2型糖尿病、低密度脂蛋白胆固醇(LDLC)、高密度脂蛋白胆固醇(HDLC)和总胆红素为中高SYNTAX评分的独立影响因素。低胆红素组有38例发生MACE,高胆红素组有25例发生MACE。两组之间无MACE生存曲线存在显著差异(χ2=4.785,P=0.029)。多因素Cox回归分析表明,男性、年龄、总胆红素和SYNTAX评分为影响MACE发生的独立因素。结论 血清胆红素是影响PCI术后心绞痛患者冠状动脉病变程度和预后的重要因素。

    Abstract:

    Aim To explore the relationship between serum bilirubin and the severity of coronary artery lesion, prognosis in patients with angina. Methods This study included 486 continuous angina patients meeting the conditions from January 1,3 to December 1,5. The subjects included 292 males and 194 females, with an average age of (61.4±13.2) years. On the day before discharge, fasting venous blood was drawn to detect total bilirubin. Coronary angiography was retrospectively analyzed and the coronary artery lesions were scored using the SYNTAX scoring system. In this study, prospective follow-up was performed. The initial event was PCI and the end event was major adverse cardiovascular events (MACE). The follow-up deadline was December 1,7. Multivariate logistic regression was used to analyze the relationship between serum bilirubin and SYNTAX scores. The Kaplan-Meier method was used to estimate the survival rate. The log-rank test was used to compare the two survival curves. The relationship between serum total bilirubin and MACE was analyzed by multivariate Cox proportional hazards regression. Results Multivariate logistic regression analysis showed that male, age, type 2 diabetes mellitus, low density lipoprotein cholesterol (LDLC), high density lipoprotein cholesterol (HDLC) and bilirubin were independent factors for the moderate-to-high SYNTAX score. MACE occurred in 38 patients of the low bilirubin group and in 25 patients of the hyperbilirubin group. There was significant difference in MACE-free survival curve between the two groups (χ2=4.785, P=0.029). Multivariate Cox regression analysis showed that male, age, bilirubin and SYNTAX scores were independent factors for the occurrence of MACE. Conclusion Serum bilirubin is an important factor affecting the degree of coronary artery lesion and long-term prognosis in PCI patients with angina.

    参考文献
    [1] 郝阳, 郭晓辰, 张军平.氧化应激和自噬在动脉粥样硬化中的作用研究新进展.中国动脉硬化杂志, 7,5(4):404-410.
    [2] 田婷, 石正洪.胆红素抗氧化系统与缺血性脑卒中的关系.中国康复理论与实践, 5,1(10):1178-1181.
    [3] Kimm H, Yun JE, Jo J, et al.Low serum bilirubin level as an independent predictor of stroke incidence:a prospective study in Korean men and women.Stroke, 9,0(11):3422-3427.
    [4] Zhang ZY, Bian LQ, Kim SJ, et al.Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males.Clin Cardiol, 2,5(5):301-306.
    [5] Ghem C, Sarmento-Leite RE, de Quadros AS, et al.Serum bilirubin concentration in patients with an established coronary artery disease.Int Heart J, 0,1(2):86-91.
    [6] Turfan M, Duran M, Poyraz F, et al.Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease.Coron Artery Dis, 3,4(1):29-32.
    [7] Canpolat U, Aytemir K, Yorgun H, et al.Association of serum total bilirubin levels with the severity, extent and subtypes of coronary atherosclerotic plaques detected by coronary CT angiography.Int J Cardiovasc Imaging, 3,9(6):1371-1379.
    [8] de Sauvage Nolting PR, Kusters DM, Hutten BA, et al.Serum bilirubin levels in familial hypercholesterolemia:a new risk marker for cardiovascular disease? .J Lipid Res, 1,2(9):1755-1759.
    [9] Kunutsor SK, Bakker SJ, Gansevoort RT, et al.Circulating total bilirubin and risk of incident cardiovascular disease in the general population.Arterioscler Thromb Vasc Biol, 5,5(3):716-724.
    [10] Ajja R1, Lee DC, Sui X, et al.Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men.Am J Cardiol, 1,8(10):1438-1442.
    [11] Mahabadi AA, Lehmann N, Mhlenkamp S, et al.Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease:the Heinz Nixdorf Recall study.Clin Res Cardiol, 4,3(8):647-653.
    [12] Okuhara K, Kisaka T, Ozono R, et al.Change in bilirubin level following acute myocardial infarction is an index for heme oxygenase activation.South Med J, 0,3(9):876-881.
    [13] 李妍妍, 周传伟, 王向明, 等.血清胆红素与冠心病冠脉病变程度关系的研究.中华全科医学, 4,2(5):670-672.
    [14] 宫京梅, 程英.血清胆红素与冠心病Gensini评分关系的研究.宁夏医学杂志, 6,8(11):979-981.
    [15] Sung KC, Shin J, Lim YH, et al.Relation of conjugated bilirubin concentrations to the presence of coronary artery calcium.Am J Cardiol, 3,2(12):1873-1879.
    [16] 曾艳, 郭志军, 王超.还原型谷胱甘肽对冠心病患者抗氧化应激的短期效果.中华高血压杂志, 8,6(10):903-906.
    [17] 苏陈, 吴峰, 张帅, 等.前列地尔与还原型谷胱甘肽联合应用对冠心病患者 PCI 术后造影剂肾病的预防作用.山东医药, 5,5(31):49-51.
    [18] 张俊芳.他汀类药物治疗冠心病对患者血清胆红素、尿酸水平的影响.国际医药卫生导报, 6,2(7):973-976.
    [19] 李曼, 于波.他汀类药物抗动脉粥样硬化的机制研究进展.心肺血管病杂志, 6,5(11):919-922.
    [20] 史小飞, 谢忠林, 任彬诚, 等.不同剂量阿托伐他汀钙短期应用对冠状动脉粥样硬化性心脏病患者血清胆红素水平的影响.现代生物医学进展, 6,6(11):2123-2126.
    [21] Sedlak TW, Saleh M, Higginson DS, et al.Bilirubin and glutathione have complementary antioxidant and cytoprotective roles.Proc Natl Acad Sci U S A, 9,6(13):5171-5176.
    [22] 习明明, 刘挺松, 牛百慧, 等.核因子相关因子-2与动脉粥样硬化的研究进展.心肺血管病杂志, 6,5(1):68-70.
    [23] Fereshtehnejad SM, Poorsattar Bejeh Mir K, Poorsattar Bejeh Mir A.Evaluation of the possible antioxidative role of bilirubin protecting from free radical related illnesses in neonates.Acta Med Iran, 2,0(3):153-163.
    [24] Yoshino S, Hamasaki S, Ishida S, et al.Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol.Heart Vessels, 3,8(2):157-165.
    [25] Thomas J, Marcus H, Matthias O, et al.Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase -1 evidence for direct and indirect antioxidant actions of bilirubin.Orig J Mel cell Car diol, 0,9(2):186-195.
    [26] Celik T, Kaya MG, Akpek M, et al.Does serum bilirubin level on admission predict TIMI flow grade and in- hospital MACE in patients with STEMI undergoing primary PCI.Angiology, 4,5(3):198-204.
    [27] Bulmer AC, Verkade HJ, Wagner KH.Bilirubin and beyond:a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection.Prog Lipid Res, 3,2(2):193-205.
    [28] Kuwano T, Miura S, Shirai K, et al.Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis:a new look at an old molecule.J Atheroscler Thromb, 1,8(7):574-583.
    [29] 周游, 张剑梅, 张琦, 等.冠心病PCI术后血清胆红素水平的变化及其与再狭窄的相关性分析.中国心血管病研究, 7,5(3):256-260.
    [30] 朱玲军, 王孝雅, 项美香, 等.术前血清胆红素预测冠心病支架再狭窄价值.中华急诊医学杂志, 6,5(8):1031-1034.
    [31] 何成毓, 彭兴, 阳飞, 等.血清胆红素水平对冠心病患者PCI术后发生冠脉再狭窄的临床价值分析.医学临床研究, 7,4(7):1402-1404.
    [32] Lin JP, O'Donnell CJ, Schwaiger JP, et al.Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study.Circulation, 6,4(14):1476-1481.
    引证文献
引用本文

耿学斌,李莉,马燚,赵碧琼,田美蓉.血清胆红素与心绞痛患者冠状动脉病变程度和预后的关系[J].中国动脉硬化杂志,2019,27(3):236~240, 253.

复制
分享
文章指标
  • 点击次数:1585
  • 下载次数: 834
历史
  • 收稿日期:2018-04-11
  • 最后修改日期:2018-06-05
  • 在线发布日期: 2019-01-28